Back to Search
Start Over
Dexamethasone should not be given to people with a chronic subdural haematoma.
- Source :
-
BMJ (Clinical research ed.) [BMJ] 2022 Jun 10; Vol. 377, pp. o1302. Date of Electronic Publication: 2022 Jun 10. - Publication Year :
- 2022
-
Abstract
- The studyHutchinson P, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural haematoma. N Engl J Med 2020;383:2616-27.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/dexamethasone-should-not-be-used-chronic-subdural-haematoma/.<br />Competing Interests: Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none. Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests.<br /> (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)
- Subjects :
- Dexamethasone adverse effects
Humans
Hematoma, Subdural, Chronic drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1756-1833
- Volume :
- 377
- Database :
- MEDLINE
- Journal :
- BMJ (Clinical research ed.)
- Publication Type :
- Academic Journal
- Accession number :
- 35688460
- Full Text :
- https://doi.org/10.1136/bmj.o1302